519 participants
Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-11-08
- Start Date:
- 2011-03-18
- Completion:
- 2011-12-14
Conditions
- Pulmonary Disease, Chronic Obstructive
Interventions
- DRUG